Selumetinib
CAS 606143-52-6
Overview
Selumetinib was originally developed as a treatment for cancers like melanoma, pancreatic cancer, colorectal cancer, and non-small cell lung
Anant Labs manufacture and furnish high quality Selumetinib impurities for global markets. Our Selumetinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
CAS606143-52-6
Mol. FormulaC17H15BrClFN4O3
Mol. Weight457.687 g/mol
IUPAC6-(4-bromo-2-chloroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide
SMILESCN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO
InChIInChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)
InChI KeyCYOHGALHFOKKQC-UHFFFAOYSA-N
Note: We are upgrading our system, Cat No will change.
Synonyms
Selumetinib606143-52-6AZD6244ARRY-1428865-[(4-BROMO-2-CHLOROPHENYL)AMINO]-4-FLUORO-N-(2-HYDROXYETHOXY)-1-METHYL-1H-BENZIMIDAZOLE-6-CARBOXAMIDEAZD 6244AZD-6244ARRY-886selumetinibumDTXSID3048944





![Chemical structure of Methyl 4-fluoro-1-methyl-5-(methylamino)-1H-benzo[d]imidazole-6-carboxylate](/molecules/ANT-SLT-003.png)